Bothell-based biopharmaceutical company Athira Pharma Inc. (Nasdaq: ATHA) is paying a $4.1 million fine due to allegations it used doctored research to land a National Institutes of Health grant.

On January 6, the Department of Justice (DOJ) announced that Athira Pharma Inc., a Washington-based biopharmaceutical company, agreed to pay over $4 million to settle allegations it violated the ...

Athira raised $204 million in its IPO and was valued at around $670 million when it went public in 2020. The company’s market capitalization is now less than $25 million.

Seattle-area biotech company Athira Pharma agreed to pay $4.07 million to settle allegations that it violated the False Claims Act by failing to disclose research misconduct to federal agencies ...